UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 17, 2021

INPIXON

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: (408) 702-2167

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

On March 17, 2021, Inpixon (the “Company”) entered into an amendment (the “Amendment”) to that certain Promissory Note, dated March 18, 2020, as amended on September 17, 2020 (as amended, the “Note”), issued to Iliad Research and Trading, L.P. (the “Lender”) in the initial principal amount of $6,465,000. Pursuant to the terms of the Amendment, the maturity date of the Note was extended from March 18, 2021 to March 18, 2022 (the “Maturity Date Extension”). In exchange for the Maturity Date Extension, the Company agreed to pay the Lender an extension fee in the amount of $96,150.14 (the “Extension Fee”), which was added to the outstanding balance of the Note. Following the application of the Extension Fee, as of March 17, 2021, the outstanding balance of the Note was $4,904,992.31.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference. The terms of the Note were previously disclosed in Item 1.01 of the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on March 20, 2020, which description is incorporated herein by reference.

To the extent required by this Item 2.03, the information included at Item 1.01 is incorporated herein by reference.

(d) Exhibits.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

3